Progenics Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Progenics Pharmaceuticals, Inc..The latest application filed is for "systems and methods for interactive adjustment of intensity windowing in nuclear medicine images".

Company Profile

17.65.74

Progenics Pharmaceuticals, Inc. - Massachusetts MA
Progenics Pharmaceuticals, Inc. - North Billerica MA US
Progenics Pharmaceuticals, Inc - New York NY US
Progenics Pharmaceuticals, Inc. - New York NY US
Progenics Pharmaceuticals, Inc. - Tarrytown NY US
Progenics Pharmaceuticals, Inc.; - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications Grant 11,424,035 - Baker August 23, 2	2022-08-23
Systems And Methods For Interactive Adjustment Of Intensity Windowing In Nuclear Medicine Images App 20220180487 - Sjostrand; Karl Vilhelm	2022-06-09
Methods Of Making Prostate Cancer Treatment Decisions App 20210330821 - Wong; Vivien	2021-10-28
Combination Therapy For Treating Metastatic Prostate Cancer App 20210330644 - Wong; Vivien	2021-10-28
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination Grant 10,973,486 - Sjostrand , et al. April 13, 2	2021-04-13
Systems And Methods For Artificial Intelligence-based Image Analysis For Cancer Assessment App 20210093249 - Anand; Aseem Undvall ; et al.	2021-04-01
Network For Medical Image Analysis, Decision Support System, And Related Graphical User Interface (gui) Applications App 20200357521 - Baker; Mark R.	2020-11-12
Systems And Methods For Automated And Interactive Analysis Of Bone Scan Images For Detection Of Metastases App 20200337658 - Sjostrand; Karl Vilhelm ; et al.	2020-10-29
Systems And Methods For Rapid Neural Network-based Image Segmentation And Radiopharmaceutical Uptake Determination App 20200342600 - Sjostrand; Karl Vilhelm ; et al.	2020-10-29
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications Grant 10,762,993 - Baker Sep	2020-09-01
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications Grant 10,665,346 - Baker	2020-05-26
Network For Medical Image Analysis, Decision Support System, And Related Graphical User Interface (gui) Applications App 20200126666 - Baker; Mark R.	2020-04-23
Network For Medical Image Analysis, Decision Support System, And Related Graphical User Interface (gui) Applications App 20200027559 - Baker; Mark R.	2020-01-23
Stable Pharmaceutical Formulations Of Methylnaltrexone App 20190358328 - Sanghvi; Suketu P. ; et al.	2019-11-28
Stable pharmaceutical formulations of methylnaltrexone Grant 10,376,584 - Sanghvi , et al. A	2019-08-13
Systems And Methods For Rapid Neural Network-based Image Segmentation And Radiopharmaceutical Uptake Determination App 20190209116 - Sjostrand; Karl Vilhelm ; et al.	2019-07-11
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications Grant 10,340,046 - Baker	2019-07-02
Network For Medical Image Analysis, Decision Support System, And Related Graphical User Interface (gui) Applications App 20180144828 - Baker; Mark R.	2018-05-24
Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof Grant 9,879,024 - Smolenskaya , et al. January 30, 2	2018-01-30
Stable Pharmaceutical Formulations Of Methylnaltrexone App 20170258911 - Sanghvi; Suketu P. ; et al.	2017-09-14
Stable pharmaceutical formulations of methylnaltrexone Grant 9,669,096 - Sanghvi , et al. June 6, 2	2017-06-06
Synthesis Of (r)-n-methylnaltrexone App 20170143700 - Doshan; Harold D. ; et al.	2017-05-25
Synthesis of (R)-N-methylnaltrexone Grant 9,597,327 - Doshan , et al. March 21, 2	2017-03-21
Crystal Forms Of (r)-n-methylnaltrexone Bromide And Uses Thereof App 20160068540 - Smolenskaya; Valeriya N. ; et al.	2016-03-10
Synthesis Of (r)-n-methylnaltrexone App 20150290187 - Doshan; Harold D. ; et al.	2015-10-15
Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof Grant 9,102,680 - Smolenskaya , et al. August 11, 2	2015-08-11
Antibodies For The Treatment Of Clostridium Difficile-associated Infection And Disease App 20150175681 - Ma; Dangshe ; et al.	2015-06-25
Antibodies for the treatment of Clostridium difficile-associated infection and disease Grant 8,986,697 - Ma , et al. March 24, 2	2015-03-24
Synthesis Of (r)-n-methylnaltrexone App 20150057303 - Doshan; Harold D. ; et al.	2015-02-26
Formulations For Parenteral Delivery Of Compounds And Uses Thereof App 20150025100 - Shah; Syed M. ; et al.	2015-01-22
Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone Grant 8,916,706 - Avey , et al. December 23, 2	2014-12-23
(S)-N-methylnaltrexone Grant 8,916,581 - Boyd , et al. December 23, 2	2014-12-23
Automatic injection device Grant D715,422 - Hall , et al. October 14, 2	2014-10-14
Automatic injection device Grant D714,932 - Hall , et al. October 7, 2	2014-10-07
Peripheral opioid receptor antagonists and uses thereof Grant 8,853,232 - Avey , et al. October 7, 2	2014-10-07
Stable Pharmaceutical Formulations Of Methylnaltrexone App 20140235664 - Sanghvi; Suketu P. ; et al.	2014-08-21
Peripheral Opioid Receptor Antagonists And Uses Thereof App 20140142132 - Avey; Alfred A. ; et al.	2014-05-22
Crystal Forms Of (r)-n-methylnaltrexone Bromide And Uses Thereof App 20140004188 - Smolenskaya; Valeriya N. ; et al.	2014-01-02
Synthesis Of R-n-methylnaltrexone App 20130323286 - Doshan; Harold D. ; et al.	2013-12-05
Preparation And Use Of (r),(r)-2,2'-bis-methylnaltrexone App 20130296570 - Avey; Alfred A. ; et al.	2013-11-07
Stable methylnaltrexone preparation Grant 8,552,025 - Sanghvi , et al. October 8, 2	2013-10-08
Peripheral opioid receptor antagonists and uses thereof Grant 8,546,418 - Avey , et al. October 1, 2	2013-10-01
Methods For Reducing Viral Load In Hiv-1 Infected Patients App 20130216526 - Olson; William C. ; et al.	2013-08-22
Antibodies For The Treatment Of Clostridium Difficile-associated Infection And Disease App 20130202618 - Ma; Dangshe ; et al.	2013-08-08
Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone Grant 8,471,022 - Avey , et al. June 25, 2	2013-06-25
Synthesis of R-N-methylnaltrexone Grant 8,343,992 - Doshan , et al. January 1, 2	2013-01-01
(s)-n-methylnaltrexone App 20120136019 - Boyd; Thomas A. ; et al.	2012-05-31
Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof App 20120009151 - Han; Amy Qi ; et al.	2012-01-12
(S)-N-methylnaltrexone Grant 8,003,794 - Boyd , et al. August 23, 2	2011-08-23
Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain Grant 7,939,083 - Dey , et al. May 10, 2	2011-05-10
Preparation And Use Of (r),(r)-2,2'-bis-methylnaltrexone App 20110100099 - Avey; Alfred A. ; et al.	2011-05-05
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion Grant 7,935,797 - Allaway , et al. May 3, 2	2011-05-03
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion Grant 7,901,685 - Allaway , et al. March 8, 2	2011-03-08
Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion Grant 7,862,994 - Allaway , et al. January 4, 2	2011-01-04
Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists Grant 7,858,298 - Allaway , et al. December 28, 2	2010-12-28
Anti-CCR5 antibody Grant 7,851,600 - Olson , et al. December 14, 2	2010-12-14
Synthesis Of R-n-methylnaltrexone App 20100311781 - Doshan; Harold D. ; et al.	2010-12-09
Pharmaceutical Formulation App 20100267758 - Sanghvi; Suketu P. ; et al.	2010-10-21
Pharmaceutical Formulation App 20100261746 - Sanghvi; Suketu P. ; et al.	2010-10-14
Pharmaceutical Formulation App 20100261745 - Sanghvi; Suketu P. ; et al.	2010-10-14
Pharmaceutical Formulation App 20100261744 - Sanghvi; Suketu P. ; et al.	2010-10-14
Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors Grant 7,736,649 - Olson , et al. June 15, 2	2010-06-15
Synthesis of R-N-methylnaltrexone Grant 7,674,904 - Doshan , et al. March 9, 2	2010-03-09
Anti-CCR5 antibody Grant 7,666,419 - Olson , et al. February 23, 2	2010-02-23
Stabilized viral envelope proteins and uses thereof Grant 7,592,014 - Binley , et al. September 22, 2	2009-09-22
(S)-N-methylnaltrexone Grant 7,563,899 - Boyd , et al. July 21, 2	2009-07-21
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell App 20090155774 - Allaway; Graham P. ; et al.	2009-06-18
(R)-N-Stereoisomers of 7,8-Saturated-4,5-Epoxy-Morphinanium Analogs App 20090047279 - Perez; Julio ; et al.	2009-02-19
Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins Grant 7,479,553 - Binley , et al. January 20, 2	2009-01-20
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection Grant 7,446,177 - Olson , et al. November 4, 2	2008-11-04
Methods for reducing viral load in HIV-1-infected patients App 20080241135 - Olson; William C. ; et al.	2008-10-02
N-Oxides of 4,5-Epoxy-Morphinanium Analogs App 20080234306 - Perez; Julio ; et al.	2008-09-25
Compounds Capable Of Inhibiting Hiv-1 Infection App 20080226651 - Litwin; Virginia M. ; et al.	2008-09-18
(S)-N-Stereoisomers of 7,8-Saturated-4,5-Epoxy-Morphinanium Analogs App 20080207669 - Perez; Julio ; et al.	2008-08-28
Method for preventing HIV-1 infection of CD4 cells App 20080187539 - Allaway; Graham P. ; et al.	2008-08-07
7,8-Saturated-4,5-Epoxy-Morphinanium Analogs App 20080176884 - Perez; Julio ; et al.	2008-07-24
Method for preventing HIV-1 infection of CD4+ Cells App 20080138897 - Allaway; Graham P. ; et al.	2008-06-12
Sequences encoding hepatitis C virus glycoproteins Grant 7,361,503 - Dumonceaux , et al. April 22, 2	2008-04-22
Compounds capable of inhibiting HIV-1 infection Grant 7,345,153 - Litwin , et al. March 18, 2	2008-03-18
Nucleic acids encoding polypeptides of anti-CCR5 antibodies App 20080015348 - Olson; William C. ; et al.	2008-01-17
Compositions comprising anti-CCR5 antibody App 20070274986 - Olson; William C. ; et al.	2007-11-29
Anti-CCR5 antibodies App 20070231327 - Olson; William C. ; et al.	2007-10-04
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion App 20070048820 - Allaway; Graham P. ; et al.	2007-03-01
Anti-CCR5 antibody App 20070031408 - Olson; William C. ; et al.	2007-02-08
Compounds capable of inhibiting HIV-1 infection App 20070025983 - Litwin; Virginia M. ; et al.	2007-02-01
Compositions and methods for inhibition of HIV-1 infection App 20070020280 - Olson; William C. ; et al.	2007-01-25
Compositions and methods for inhibition of HIV-1 infection Grant 7,138,119 - Olson , et al. November 21, 2	2006-11-21
Methods for inhibiting HIV-1 infection App 20060233798 - Olson; William C. ; et al.	2006-10-19
Anti-CCR5 antibody Grant 7,122,185 - Olson , et al. October 17, 2	2006-10-17
Methods for inhibiting HIV-1 infection Grant 7,118,859 - Litwin , et al. October 10, 2	2006-10-10
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection App 20060198855 - Olson; William C. ; et al.	2006-09-07
Uses of a chemokine receptor for inhibiting HIV-1 infection App 20060194244 - Allaway; Graham P. ; et al.	2006-08-31
Cells expressing a CD4-IgG2 chimeric heterotetramer Grant 7,070,991 - Beaudry , et al. July 4, 2	2006-07-04
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion App 20060140977 - Allaway; Graham P. ; et al.	2006-06-29
Methods for inhibiting HIV-1 infection Grant 7,060,273 - Olson , et al. June 13, 2	2006-06-13
Stabilized viral envelope proteins and uses thereof App 20060094049 - Binley; James M. ; et al.	2006-05-04
Stabilized viral envelope proteins and uses thereof Grant 7,022,324 - Binley , et al. April 4, 2	2006-04-04
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection Grant 7,022,323 - Olson , et al. April 4, 2	2006-04-04
Method for preventing HIV-1 infection of CD4+ cells App 20060029932 - Allaway; Graham P. ; et al.	2006-02-09
Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same Grant 6,972,126 - Allaway , et al. December 6, 2	2005-12-06
Sulfated CCR5 peptides for HIV-1 infection Grant 6,908,734 - Dragic , et al. June 21, 2	2005-06-21
Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto App 20040228869 - Olson, William C. ; et al.	2004-11-18
Stabilized viral envelope proteins and uses thereof App 20040224308 - Binley, James M. ; et al.	2004-11-11
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Grant 6,737,267 - Maddon , et al. May 18, 2	2004-05-18
Uses of a chemokine receptor for inhibiting HIV-1 infection App 20040086528 - Allaway, Graham P. ; et al.	2004-05-06
Compositions and methods for inhibition of HIV-1 infection App 20040062767 - Olson, William C. ; et al.	2004-04-01
Stabilized viral envelope proteins and uses thereof Grant 6,710,173 - Binley , et al. March 23, 2	2004-03-23
Sulfated CCR5 peptides for HIV-1 infection App 20030139571 - Dragic, Tatjana ; et al.	2003-07-24
Sulfated CCR5 peptides for HIV-1 infection Grant 6,548,636 - Dragic , et al. April 15, 2	2003-04-15
Method for preventing HIV-1 infection of CD4+ cells App 20020155429 - Allaway, Graham P. ; et al.	2002-10-24
CD4-gamma2 and CD4-IGG2 chimeras Grant 6,451,313 - Maddon , et al. September 17, 2	2002-09-17
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell App 20020045161 - Allaway, Graham P. ; et al.	2002-04-18
Method for preventing HIV-1 infection of CD4+ cells Grant 6,344,545 - Allaway , et al. February 5, 2	2002-02-05
Compounds capable of inhibiting HIV-1 infection App 20010046512 - Litwin, Virginia M. ; et al.	2001-11-29
Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion Grant 6,261,763 - Allaway , et al. July 17, 2	2001-07-17
Method for preventing HIV-1 infection of CD4.sup.+ cells Grant 6,107,019 - Allaway , et al. August 22, 2	2000-08-22
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Grant 6,034,223 - Maddon , et al. March 7, 2	2000-03-07
Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same Grant 5,817,767 - Allaway , et al. October 6, 1	1998-10-06

Company Registrations

NCAGE Code	34KE9	PROGENICS PHARMACEUTICALS, INC.!DBA PROGENICS PHARMACEUTICALS
CAGE Code	34KE9	PROGENICS PHARMACEUTICALS, INC. PROGENICS PHARMACEUTICALS
S.A.M. Registration	34KE9 [195551247]	PROGENICS PHARMACEUTICALS, INC. PROGENICS PHARMACEUTICALS
SEC	0000835887	PROGENICS PHARMACEUTICALS INC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.